SNODGRASS H. RALPH
Insider CIK 1415876 · VSTA PRES./CHIEF SCIENTIFIC OFFICER, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VTGN | A Award | 2021-12-31 | 2022-01-03 | 3,623 | $1.66 | $6.0K | 64,958 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | G Gift | 2021-09-02 | 2021-09-03 | 1,111 | — | $0 | 61,335 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | G Gift | 2021-08-23 | 2021-09-03 | 740 | — | $0 | 33,901 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | P Buy | 2021-08-17 | 2021-08-18 | 3,750 | $2.73 | $10.2K | 34,641 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2021-06-30 | 2021-07-02 | 3,391 | $1.95 | $6.6K | 91,115 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2020-12-31 | 2021-01-04 | 5,000 | $0.45 | $2.3K | 87,724 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-12-30 | 2021-01-04 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award | 2020-06-30 | 2020-07-01 | 5,000 | $0.45 | $2.3K | 67,724 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2020-04-23 | 2020-04-27 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | P Buy | 2019-11-20 | 2019-11-21 | 15,000 | $0.34 | $5.1K | 15,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-10-21 | 2019-10-22 | 175,000 | — | $0 | 175,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2019-05-23 | 2019-05-28 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise deriv | 2019-03-13 | 2019-03-14 | 2,500 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | M Exercise | 2019-03-13 | 2019-03-14 | 2,500 | $1.50 | $3.8K | 62,724 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 12,500 | — | $0 | 12,500 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 80,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 125,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 125,000 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 12,500 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 1,250 | — | $0 | 1,250 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 2,500 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-29 | 2018-08-31 | 2,500 | — | $0 | 2,500 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | D To issuer deriv | 2018-08-29 | 2018-08-31 | 1,250 | — | $0 | 0 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-08-05 | 2018-08-06 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2018-02-02 | 2018-02-05 | 175,000 | — | $0 | 175,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-09-19 | 2017-09-20 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2017-04-26 | 2017-04-28 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-11-09 | 2016-11-10 | 80,000 | — | $0 | 80,000 | SEC↗ |
| VTGN VistaGen Therapeutics, Inc | A Award deriv | 2016-06-19 | 2016-06-21 | 125,000 | — | $0 | 125,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 150,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 100,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 7,500 | — | $0 | 7,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 7,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 2,500 | — | $0 | 2,500 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 2,500 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-11-11 | 2015-11-13 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2015-11-11 | 2015-11-13 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-09-02 | 2015-09-03 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2015-01-11 | 2015-01-13 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2014-03-19 | 2014-03-21 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2014-03-19 | 2014-03-21 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 150,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 150,000 | — | $0 | 150,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 250,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 250,000 | — | $0 | 250,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 100,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 50,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | A Award deriv | 2013-12-20 | 2013-12-24 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | D To issuer deriv | 2013-12-20 | 2013-12-24 | 25,000 | — | $0 | 0 | SEC↗ |
| VSTA VistaGen Therapeutics, Inc | J Other deriv | 2013-03-03 | 2013-03-05 | 1,000,000 | — | $0 | 1,000,000 | SEC↗ |